rp3

This secondary analysis of the DOSE VF trial highlights double sequential external defibrillation (DSED) as a superior strategy over standard and vector change defibrillation for refractory ventricular fibrillation (RVF) in out-of-hospital cardiac arrest, improving survival rates and neurological outcomes significantly. Implementing DSED in prehospital protocols is recommended.

JC: Does the outcome from refractory VF differ from recurrent VF in DOSE-VF patients?

This secondary analysis of the DOSE VF trial highlights double sequential external defibrillation (DSED) as a superior strategy over standard and vector change defibrillation for refractory ventricular fibrillation (RVF) in out-of-hospital cardiac arrest, improving survival rates and neurological outcomes significantly.

JC: Does the outcome from refractory VF differ from recurrent VF in DOSE-VF patients? Read More »

Scroll to Top